The effect of probiotic soy milk in the treatment of type 2 diabetes
Not Applicable
- Conditions
- type 2 diabetes.Insulin-dependent diabetes mellitus
- Registration Number
- IRCT201405265062N8
- Lead Sponsor
- Isfahan University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patient with type 2 diabetes; between 25-75 years old; no consumption of vitamin supplement; antioxidants; mineral; omega-3 since 3 weeks ago.
Exclusion criteria: smokers; pregnant and lactating women; patients with liver disease; IBS; thyroid disease; Rheumatoid arthritis; infection; heart diseases; sever infection; disobedience of recommended diet
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MLH1 promoter methylation. Timepoint: Before and after intervention. Method of measurement: MethyQESD method.
- Secondary Outcome Measures
Name Time Method Serum concentration of 8-Oxo-2'-deoxyguanosine. Timepoint: Before intervention and after eighth week. Method of measurement: Eliza method.;MSH2 promoter methylation. Timepoint: Before intervention and after eighth week. Method of measurement: methyQESD method.;The activity of superoxide reductase. Timepoint: Before intervention and after eighth week. Method of measurement: Eliza method.